Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP4408764B2 - Method for producing apparently IgG-containing food - Google Patents
[go: Go Back, main page]

JP4408764B2 - Method for producing apparently IgG-containing food - Google Patents

Method for producing apparently IgG-containing food Download PDF

Info

Publication number
JP4408764B2
JP4408764B2 JP2004219223A JP2004219223A JP4408764B2 JP 4408764 B2 JP4408764 B2 JP 4408764B2 JP 2004219223 A JP2004219223 A JP 2004219223A JP 2004219223 A JP2004219223 A JP 2004219223A JP 4408764 B2 JP4408764 B2 JP 4408764B2
Authority
JP
Japan
Prior art keywords
antibody
milk
food
igg antibody
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004219223A
Other languages
Japanese (ja)
Other versions
JP2006034173A (en
Inventor
瑞夫 矢嶋
聡 岩附
博 塩野谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asama Chemical Co Ltd
Original Assignee
Asama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asama Chemical Co Ltd filed Critical Asama Chemical Co Ltd
Priority to JP2004219223A priority Critical patent/JP4408764B2/en
Publication of JP2006034173A publication Critical patent/JP2006034173A/en
Application granted granted Critical
Publication of JP4408764B2 publication Critical patent/JP4408764B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Description

本発明は、抗体含有明らか食品およびその製造方法に関する。   The present invention relates to an antibody-containing apparent food and a method for producing the same.

抗体は、体内で産生され、免疫機能を奏するが、加齢とともに産生量は減少するため、免疫機能は低下する。また、ストレスや免疫抑制作用を有する医薬品の使用によっても抗体産生は低下する。消化管は免疫系の最前線であり、抗体の摂取によって消化管免疫を高めることができるので、健康を増進し、病気からの回復を早め、健康長寿が期待できる。   The antibody is produced in the body and exerts an immune function. However, since the production amount decreases with age, the immune function decreases. Antibody production is also reduced by the use of pharmaceuticals having stress and immunosuppressive effects. The gastrointestinal tract is at the forefront of the immune system. By ingesting antibodies, gastrointestinal immunity can be enhanced, so that health can be improved, recovery from illness can be accelerated, and healthy longevity can be expected.

例えば、牛乳中の抗体を人、動物が摂取することにより、消化管において疾病の原因となる細菌やウイルスによる病気の治療と予防に有効であることや、消化管内の微生物バランスを健常に保ち、健康増進に役立つことが報告されている(非特許文献1参照)。また、消化管には大腸菌その他グラム陰性菌が寄生し、グラム陰性菌の菌体成分である内毒素(エンドトキシン)が体内に移行すると、エンドトキシンショックや、血栓症などの重篤な病態となることが知られているが、外科手術に先立って牛乳中の抗体を摂取するにより、その抗体がエンドトキシンの毒性を無害化して、エンドトキシンによる傷害を防ぐことができることも報告されている(非特許文献2参照)。   For example, humans and animals ingesting antibodies in milk can be effective in the treatment and prevention of diseases caused by bacteria and viruses that cause diseases in the digestive tract, keep the microbial balance in the digestive tract healthy, It is reported that it is useful for health promotion (refer nonpatent literature 1). In addition, Escherichia coli and other Gram-negative bacteria are parasitic on the gastrointestinal tract, and when endotoxin (Endotoxin), which is a gram-negative bacterial cell component, moves into the body, endotoxin shock and serious pathological conditions such as thrombosis may occur. However, it has also been reported that by ingesting an antibody in milk prior to surgery, the antibody can detoxify endotoxin toxicity and prevent endotoxin damage (Non-patent Document 2). reference).

ヒトにおいて消化管や、呼吸器などの粘膜に分泌される抗体の合成速度はkg体重あたり、24mg/日とされ(非特許文献3参照)、成人では毎日約1gが分泌されていることから、病気快復、健康増進のためにはこの量を補う抗体の摂取が望ましい。   The synthesis rate of antibodies secreted in the digestive tract and mucous membranes of the respiratory tract in humans is 24 mg / day per kg body weight (see Non-Patent Document 3), and about 1 g is secreted daily in adults. In order to recover from disease and improve health, it is desirable to take antibodies to supplement this amount.

ところで、抗体は、牛の生乳中に0.03〜0.71mg/ml含まれているが(非特許文献4参照)、殺菌工程中でそのほとんどが熱変性し、活性を失ってしまうため、通常、市販の牛乳中には未変性の抗体は残存していない。   By the way, although the antibody is contained in the raw milk of cattle 0.03-0.71 mg / ml (see Non-Patent Document 4), most of it is heat-denatured during the sterilization process and loses its activity. Usually, no native antibody remains in commercially available milk.

現在、乳由来の抗体を摂取しようとするとき、いわゆる健康食品として抗体を含有した錠剤、カプセル、粉末状の製品があり、また、栄養補助食品としてのプロテインパウダーの一部にも抗体を含有するものがあり、これらを摂取することができる。しかし、これらは医薬品的に丸ごと飲み込んだり、水や牛乳等に懸濁させて流し込んだりするもので、およそおいしさを味わい、楽しみつつ食するような類のものではなく、いわゆる「明らか食品」(見た目にも薬と誤認するようなことはなく、通常の食品の形態および方法によって日常的に食べられる食品)の中で、高濃度に抗体を含有した食品は未だ見当たらない。それは、乳由来の抗体含有原料は食品の加工の段階で加熱殺菌され、抗体が失活してしまうためと考えられる。
Korhonen H. et al. Bovine milk antibodies for health, British J. Nutrition,84,suppl.1,S135-S146 (2000) Bolke E, et al. Shock 17, 9-12 (2002) ウイリアムE.ポール編/多田富雄監訳、基礎免疫学(東京大学出版会)1986年、上181頁 E.Li-Chan et al. Food & Agricultural Immunology, 6,443-451(1994)
Currently, when trying to take antibodies derived from milk, there are tablets, capsules and powdered products that contain antibodies as so-called health foods, and antibodies are also included in some protein powders as dietary supplements. There are things and you can take them. However, they are swallowed in the form of medicinal products, or suspended in water, milk, etc., and are not something that tastes delicious and is enjoyable. The food is not misidentified as a drug in appearance, and the food containing the antibody at a high concentration is not yet found among the foods that can be eaten on a daily basis by the form and method of ordinary food. This is presumably because the antibody-containing raw material derived from milk is heat-sterilized at the stage of food processing and the antibody is deactivated.
Korhonen H. et al. Bovine milk antibodies for health, British J. Nutrition, 84, suppl.1, S135-S146 (2000) Bolke E, et al. Shock 17, 9-12 (2002) William E.E. Edited by Paul / Director, Tomio Tada, Basic Immunology (The University of Tokyo Press), 1986, 181 pages E. Li-Chan et al. Food & Agricultural Immunology, 6,443-451 (1994)

本発明は、味わいつつ食することのできる明らか食品であって、より高濃度の抗体を含有する食品およびその製造方法を提供することを課題とする。   An object of the present invention is to provide a food that is a clear food that can be eaten while tasting and contains a higher concentration of antibody, and a method for producing the same.

本発明者らは、乳清タンパクのような、より高濃度の抗体を含有する食品原料を加工食品に一定条件のもとに配合することで前記課題を解決できることを見出し、加熱条件によっては、抗体が失活しないで50%以上残存することを見つけ、本発明に到達した。   The present inventors have found that the above-mentioned problem can be solved by blending a food material containing a higher concentration of antibody, such as whey protein, into a processed food under certain conditions, and depending on heating conditions, The inventors found that the antibody remained at 50% or more without being inactivated, and reached the present invention.

すなわち、本発明は下記のとおりである。
1)乳由来の抗体1.5mg/g以上を含有することを特徴とする抗体含有明らか食品(但し、乳酸菌およびビフィズス菌類を107/g以上含有しない)、
2)乳由来の抗体を3mg/g以上含有する前記1)に記載の抗体含有明らか食品、
3)乳由来の抗体を10mg/g以上含有する前記1)に記載の抗体含有明らか食品、
4)乳由来の抗体が乳清タンパク中の抗体である前記1)〜3)のいずれか1項に記載の抗体含有明らか食品、
5)抗体含有明らか食品が乳製品または冷菓である前記1)〜4)のいずれか1項に記載の抗体含有明らか食品、
6)乳由来の抗体を含む明らか食品または該明らか食品の乳由来の抗体を含む部分を、抗体が50%以上残存する条件で加熱殺菌を行うことを特徴とする前記1)〜5)のいずれか1項に記載の抗体含有明らか食品の製造方法、
7)加熱殺菌を、抗体含有部分の糖質含量が7.5質量%以上となるように調製して行う前記6)に記載の抗体含有明らか食品の製造方法。
That is, the present invention is as follows.
1) Antibody-containing apparent food containing 1.5 mg / g or more of milk-derived antibody (however, it does not contain 10 7 / g or more of lactic acid bacteria and bifidobacteria),
2) The antibody-containing apparent food according to 1) above, which contains 3 mg / g or more of milk-derived antibody,
3) The antibody-containing apparent food according to 1) above containing 10 mg / g or more of milk-derived antibody,
4) The antibody-containing apparent food according to any one of 1) to 3) above, wherein the milk-derived antibody is an antibody in whey protein;
5) The antibody-containing apparent food according to any one of 1) to 4) above, wherein the antibody-containing apparent food is a dairy product or a frozen dessert;
6) Any one of the above 1) to 5) , wherein the apparent food containing milk-derived antibody or the portion of the apparent food containing milk-derived antibody is heat sterilized under the condition that 50% or more of the antibody remains. A method for producing an antibody-containing apparent food according to claim 1,
7) The method for producing an antibody-containing apparent food according to 6) above, wherein the heat sterilization is performed such that the carbohydrate content of the antibody-containing portion is 7.5% by mass or more.

請求項1記載の発明によれば、高濃度の抗体を含有することにより、免疫賦活作用を期待できる食品を提供することができる。請求項2記載の発明によれば、抗体濃度のさらに高い食品を提供することができる。また、請求項3記載の発明によれば、抗体濃度の特に高い食品を提供することができる。請求項4記載の発明によれば乳清タンパク中の高濃度の抗体を含有する食品を提供することができる。さらに請求項記載の発明のとおり、抗体含有明らか食品は乳製品、冷菓としておいしさを味わいつつ免疫賦活効果を享受できる。請求項記載の発明によると、加熱しても抗体が50%残存する食品を製造することができる。請求項記載の発明によると7.5質量%の糖質の存在で抗体の安定性が高められるので、抗体残存量の高い明らか食品を製造することができる。 According to invention of Claim 1, the foodstuff which can anticipate an immunostimulatory effect can be provided by containing a high concentration antibody. According to the invention described in claim 2, a food having a higher antibody concentration can be provided. In addition, according to the invention described in claim 3, a food with a particularly high antibody concentration can be provided. According to invention of Claim 4, the foodstuff containing the high concentration antibody in whey protein can be provided. Further, according to the invention described in claim 5 , the antibody-containing apparent food can enjoy an immunostimulatory effect while tasting the deliciousness as a dairy product or a frozen dessert. According to the sixth aspect of the present invention, a food in which 50% of the antibody remains even when heated can be produced. According to the seventh aspect of the invention, since the stability of the antibody is enhanced by the presence of 7.5% by mass of the carbohydrate, it is possible to produce an apparent food with a high antibody residual amount.

本発明の抗体含有食品は、乳由来の抗体として、抗体濃度の高い抗体原料、例えば乳清タンパク、初乳に含まれる抗体を含有することが好ましい。乳清タンパク、初乳は抗体濃度が高いので、高濃度の抗体含有食品の抗体原料として好適である。市販の乳清タンパクには生乳に含まれる抗体が移行して高濃度で存在し、変性、失活せずにその活性を保っているものがある。乳清タンパクとしては、市販のものを用いることができるが、抗体は高温において変性を受けるため、製造工程中での熱履歴の少ないもの、例えばイオン交換膜法や限外ろ過膜法で製造したものを配合するのが好ましい。より好ましくは活性を保持した抗体を1質量%以上含有している乳清タンパクである。   The antibody-containing food of the present invention preferably contains, as milk-derived antibodies, antibody materials having a high antibody concentration, such as whey protein and antibodies contained in colostrum. Since whey protein and colostrum have high antibody concentrations, they are suitable as antibody raw materials for foods containing high concentrations of antibodies. Some commercially available whey proteins migrate to exist in high concentrations of antibodies contained in raw milk and retain their activity without denaturation and inactivation. As whey protein, commercially available ones can be used, but antibodies undergo denaturation at high temperatures, so those with little heat history during the production process, such as ion exchange membrane method or ultrafiltration membrane method, were used. It is preferable to blend them. More preferably, it is a whey protein containing 1% by mass or more of an antibody that retains its activity.

乳清タンパクの原料となる乳は牛、ヤギ、ヒツジ、馬等いずれの哺乳動物の乳でもよい。また、その乳はワクチン接種を受けた哺乳動物から採取された乳でも、ワクチン接種を受けていない哺乳動物から採取された乳でもよい。   Milk used as a raw material for whey protein may be milk of any mammal such as cow, goat, sheep and horse. The milk may be milk collected from a mammal that has been vaccinated or milk collected from a mammal that has not been vaccinated.

初乳を抗体原料として用いる場合、牛、ヤギ、ヒツジ、馬等いずれの哺乳動物の初乳でもよく、また、その初乳はワクチン接種を受けた哺乳動物から採取された初乳でも、ワクチン接種を受けていない哺乳動物から採取された初乳でもよい。初乳とは、分泌開始後、4〜5日までに分泌される乳をいう。初乳には常乳に比べて、数十〜百倍の高濃度の抗体が含まれていることが知られている(太田實、化学と生物 37(2), 107-112(1999))。   When colostrum is used as an antibody raw material, colostrum from any mammal such as cattle, goats, sheep, horses, etc. may be used, and the colostrum may be colostrum collected from a vaccinated mammal. It may be colostrum collected from a mammal that has not received it. Colostrum means milk secreted by 4 to 5 days after the start of secretion. It is known that colostrum contains an antibody at a concentration several tens to a hundred times higher than that of regular milk (Akira Ota, Chemistry and Biology 37 (2), 107-112 (1999)).

本発明の抗体含有明らか食品は、食品1g中に、乳由来の抗体を1.5mg以上含有する。好ましい含有量は1.5〜200mg/gである。また、抗体含量が3mg/g以上の場合、抗体の免疫賦活機能がより期待でき、さらに好ましい。さらに好ましい含有量は3〜200mg/gである。また、抗体含量が10mg/g以上の場合、さらに高い抗体の免疫賦活機能がより期待でき、より好ましい。さらにより好ましい含有量は10〜200mg/gである。   The antibody-containing apparent food of the present invention contains 1.5 mg or more of milk-derived antibody in 1 g of food. A preferable content is 1.5 to 200 mg / g. Moreover, when the antibody content is 3 mg / g or more, the immunostimulatory function of the antibody can be expected more and more preferably. A more preferable content is 3 to 200 mg / g. Moreover, when the antibody content is 10 mg / g or more, a higher antibody immunostimulatory function can be expected more and more preferably. An even more preferable content is 10 to 200 mg / g.

本発明の抗体含有食品は、抗体以外の免疫賦活機能を有する成分をさらに含有することができる。抗体以外の免疫賦活成分をさらに含有することにより、さらに免疫賦活機能を高めることができる。抗体以外の免疫賦活成分としては、例えば、しいたけ、エノキタケ、アガリクス、メシマコブ、霊芝等の担子菌類;原核細胞のDNA、真核細胞のDNA、ヌクレオチド等の核酸組成物;プロポリス;キチン;キトサン;ラクトフェリン;フコイダン;エキナセア;タヒボ;米糠;酵母;ビタミンC、ビタミンE、カロチノイド、緑茶成分、ポリフェノール等のSOD様物質;SOD含有医薬組成物(米国特許6045809);石蓮花、朝鮮人参、うこん等の漢方成分等免疫賦活機能の知られている成分を挙げることができるが、免疫賦活機能を有する成分であればこれらに限定されない。これらは抽出エキス、その乾燥粉末等としても用いることができる。   The antibody-containing food of the present invention can further contain components having an immunostimulatory function other than antibodies. By further containing an immunostimulatory component other than the antibody, the immunostimulatory function can be further enhanced. Examples of immunostimulatory components other than antibodies include basidiomycetes such as Shiitake, Enokitake, Agaricus, Meshimakobu, and Ganoderma; Nucleic acid compositions such as prokaryotic DNA, eukaryotic DNA, and nucleotides; propolis; chitin; chitosan; Lactoferrin; fucoidan; echinacea; tahibo; rice bran; yeast; Although components having known immunostimulatory functions such as Kampo components can be listed, the components are not limited to these as long as they have immunostimulatory functions. These can also be used as an extract extract, its dry powder and the like.

本発明において、明らか食品とは、「明らかに食品と認識される物」の通称であり、外観、形状および成分本質からみて社会通念上、容易に「食品」と認識されるものをいい、厚生省薬務局監視指導課、東京都衛生局薬務部監修「医薬品・化粧品等広告の実際‘94」(薬業時報社)にも記載されている用語である。医薬品や栄養補助食品に通常、用いられている形態である錠剤、カプセル、粉末等の形状でない飲食品であり、加工食品、調理食品、菓子、飲料、調味料等を包含する。   In the present invention, the apparent food is a common name of “a product that is clearly recognized as food”, and is a food that is easily recognized as “food” in terms of social wisdom in terms of appearance, shape, and component essence. It is a term also described in “Pharmaceuticals and Cosmetics Advertising Actually '94” (Pharmaceutical Times Publishing Co., Ltd.), supervised by the Pharmaceutical Affairs Bureau Surveillance and Guidance Division, the Tokyo Metropolitan Government Bureau of Health Administration. It is a food and drink that is not in the form of tablets, capsules, powders, etc., which are usually used in pharmaceuticals and nutritional supplements, and includes processed foods, cooked foods, confectionery, beverages, seasonings and the like.

本発明の明らか食品としては、様々な形態の食品があるが、例えば加工乳、乳飲料等の乳製品(乳酸菌、ビフィズス菌類の含有量が10/g未満のもの)、果汁飲料、野菜汁飲料、清涼飲料、豆乳等の嗜好飲料、ドレッシング、ふりかけ等の調味料、アイスクリーム、ソフトクリーム等の冷菓、ゼリー等のデザート類、マーガリン、スプレッド、トッピングソース、コンデンスミルク、ホイップクリーム、コーヒーホワイトナー、チョコレート、チューインガム等の菓子等を挙げることができる。 The apparent food of the present invention includes various forms of food, for example, dairy products such as processed milk and milk drinks (with a content of lactic acid bacteria and bifidobacteria of less than 10 7 / g), fruit juice drinks, vegetable juices Beverages, soft drinks, soy milk and other favorite beverages, seasonings such as dressing and sprinkles, ice cream, soft ice cream and other desserts, jelly and other desserts, margarine, spreads, topping sauce, condensed milk, whipped cream, coffee whitener And confectionery such as chocolate and chewing gum.

本発明の抗体含有明らか食品は、その製造方法に限定はなく、通常の製造方法によることができる。明らか食品の製造または調理時に原料の一つとして、抗体原料である乳清タンパクや初乳を添加して製造、調理することにより、得ることができる。調理または製造に際しては、抗体原料を添加した後は抗体が50%以上残存する条件で加熱殺菌することが望ましい。抗体が50%以上残存する加熱殺菌条件としては、例えば、60℃、30分間またはこれと同等以下の加熱条件が挙げられるが、図1に示すように食品によってはさらに温度を上げることもできる。糖質を7.5質量%以上含ませることにより、抗体が熱に対して安定になり、より高い温度での加熱が可能となるので、糖質を添加して加熱殺菌することもできる。   The production method of the antibody-containing apparent food of the present invention is not limited, and can be obtained by a normal production method. Obviously, it can be obtained by preparing and cooking whey protein or colostrum, which is an antibody raw material, as one of the raw materials during the production or cooking of food. In cooking or manufacturing, it is desirable to sterilize by heating under the condition that 50% or more of the antibody remains after the antibody raw material is added. Examples of the heat sterilization condition in which 50% or more of the antibody remains include, for example, a heat condition of 60 ° C. for 30 minutes or less. However, depending on the food, the temperature can be further increased as shown in FIG. By including 7.5% by mass or more of saccharide, the antibody becomes stable against heat and can be heated at a higher temperature. Therefore, saccharides can be added and sterilized by heating.

また、乳清タンパクや初乳等の抗体を含む部分を他の食品原料部分に添加する前に、この抗体を含む部分を抗体が50%以上残存する条件で加熱殺菌し、抗体を含まない部分(
前記他の食品原料部分)を通常の殺菌条件で加熱殺菌し、両者を無菌的に混合することで、抗体含有明らか食品を得ることもできる。
In addition, before adding a part containing antibodies such as whey protein or colostrum to other food ingredient parts, the part containing these antibodies is heat-sterilized under the condition that 50% or more of the antibodies remain, and the part not containing antibodies (
The above-mentioned other food raw material portion) can be heat-sterilized under normal sterilization conditions, and both can be mixed aseptically to obtain antibody-containing apparent food.

また、濾過や電子線、ガンマ線、紫外線、高電圧パルス、振動磁場、閃光パルス、超音波、高圧処理、DPCO(Dense Phase Carbon Dioxide)等を用いた非加熱殺菌を行って抗体明らか食品を得ることもできる。 Moreover, non-heat sterilization using filtration, electron beam, gamma ray, ultraviolet ray, high voltage pulse, oscillating magnetic field, flash pulse, ultrasonic wave, high pressure treatment, DPCO 2 (Dense Phase Carbon Dioxide), etc. is performed to obtain an antibody-obtained food. You can also.

図1には、食品に乳清タンパクを添加し、各温度で30分間加熱したときの各食品中の抗体残存率を示す。食品として、それぞれ市販の牛乳、ポタージュスープ、野菜果汁飲料を選び、それぞれ2質量%、3質量%、3質量%の乳清タンパクを添加し、その他に、乳清タンパクの10質量%水溶液について、60〜72℃の範囲で加熱したときの各食品中の抗体量を測定し、抗体の残存率を算出した。抗体量の測定方法は後記実施例に示す方法によった。   FIG. 1 shows the antibody residual ratio in each food when whey protein is added to the food and heated at each temperature for 30 minutes. As food, select commercially available milk, potage soup, vegetable fruit juice beverages, add 2% by weight, 3% by weight, 3% by weight whey protein, respectively, and in addition, about 10% by weight aqueous solution of whey protein, The amount of antibody in each food when heated in the range of 60 to 72 ° C. was measured, and the residual ratio of the antibody was calculated. The antibody amount was measured by the method described in the examples below.

図1に見る通り、牛乳(乳清タンパク添加後のpH6.5)においては、68℃、30分間の加熱で抗体は50%以上残存し、乳清タンパク10質量%水溶液(同pH6.4)においては、67℃、30分間で50%程度残存し、ポタージュスープ(同pH5.3)の場合には66℃、30分間で50%残存している。一方、野菜果汁飲料(同pH4.5)においては、60℃、30分間の加熱で50%以上の残存率になっている。このように、対象食品ごとに加熱殺菌の条件を選ぶことにより、抗体を50%以上残存させることができることがわかる。   As shown in FIG. 1, in milk (pH 6.5 after addition of whey protein), the antibody remains at 50% or more by heating at 68 ° C. for 30 minutes, and a 10% whey protein aqueous solution (pH 6.4). In the case of potage soup (same pH: 5.3), 50% remains at 66 ° C. for 30 minutes. On the other hand, in vegetable juice drinks (same pH 4.5), the residual rate is 50% or more by heating at 60 ° C. for 30 minutes. Thus, it can be seen that 50% or more of the antibody can be left by selecting the heat sterilization conditions for each target food.

以上のことから、対象食品が異なっても、予備試験を行うことにより、抗体が50%以上残存する加熱条件を定めることができ、その条件と同等かそれより低い条件で加熱殺菌すればよい。   From the above, even if the target food is different, by performing a preliminary test, it is possible to determine the heating condition in which the antibody remains at 50% or more, and it is only necessary to sterilize by heating under the same or lower condition.

一方、発明者らは抗体の熱安定性を高める物質の検索を行ったところ、糖質を添加することにより目的を達成できることを発見した。   On the other hand, the inventors have searched for substances that enhance the thermal stability of antibodies, and have found that the object can be achieved by adding carbohydrates.

図2には、市販の牛乳に乳清タンパクを添加し、さらにショ糖を添加して各温度で30分間加熱したときの抗体の残存率を示す。この試験においては、ショ糖を無添加、3質量%、5.5質量%、10.5質量%、25.5質量%、40.5質量%添加したので、牛乳中にもともと含まれる4.5質量%の糖質と合わせると、それぞれの牛乳中の糖質含量は4.5質量%、7.5質量%、10質量%、15質量%、30質量%、45質量%となった。これらの牛乳にいずれも乳清タンパクを2質量%添加し、60〜80℃の範囲で加熱したときの各牛乳中の抗体量を測定し、抗体の残存率を算出した。   FIG. 2 shows the residual ratio of antibody when whey protein is added to commercially available milk, sucrose is further added, and the mixture is heated at each temperature for 30 minutes. In this test, sucrose was not added, and 3% by mass, 5.5% by mass, 10.5% by mass, 25.5% by mass, and 40.5% by mass were added. When combined with 5% sugar by weight, the sugar content in each milk was 4.5%, 7.5%, 10%, 15%, 30% and 45% by weight. In each of these milks, 2% by mass of whey protein was added and the amount of antibody in each milk when heated in the range of 60 to 80 ° C. was measured to calculate the residual ratio of the antibody.

図3には、ショ糖の替わりにエリスリトールを用いて、上記と同様の試験を行った結果を示す。この他、果糖、ガラクトオリゴ糖を用いた場合にも同様の熱安定性が得られた。   FIG. 3 shows the results of a test similar to the above using erythritol instead of sucrose. In addition, the same thermal stability was obtained when fructose and galactooligosaccharide were used.

図2および図3に見る通り、糖質含量が質7.5量%であれば70℃、30分間の加熱で、いずれにおいても抗体は50%以上残存していた。また、糖質含量が多くなるに従って抗体の熱安定性は高まり、糖質含量が45質量%では、77℃、30分間の加熱でも抗体は50%以上残存していた。   As shown in FIGS. 2 and 3, when the saccharide content was 7.5% by mass, the antibody remained at 50% or more by heating at 70 ° C. for 30 minutes. In addition, as the carbohydrate content increased, the thermal stability of the antibody increased. When the carbohydrate content was 45% by mass, the antibody remained at 50% or more even after heating at 77 ° C. for 30 minutes.

以上のことから、抗体含有明らか食品の製造または調理工程において、抗体を含む部分の糖質含量が7.5質量%以上となるように調整すると、抗体の熱に対する安定性が高められ、より高い温度で加熱することができ、同じ加熱温度では製品食品中の抗体の残存率を高めることができることがわかる。   From the above, in the production or cooking process of antibody-containing apparent food, when the carbohydrate content of the antibody-containing portion is adjusted to be 7.5% by mass or more, the stability of the antibody to heat is enhanced and higher. It can be seen that the residual ratio of antibodies in the product food can be increased at the same heating temperature.

このような効果を奏する糖質としては、ブドウ糖、果糖等の単糖類、ショ糖、乳糖等の二糖類、フラクトオリゴ糖、イソマルトオリゴ糖等のオリゴ糖類、グリセリン、ソルビトール、エリスリトール等の糖アルコール類等を用いることができる。糖質は単体ないしは複数種を混合して添加してもよいし、食品原料中に元来含まれる糖質も利用できる。   Examples of saccharides having such effects include monosaccharides such as glucose and fructose, disaccharides such as sucrose and lactose, oligosaccharides such as fructooligosaccharides and isomaltoligosaccharides, and sugar alcohols such as glycerin, sorbitol, and erythritol. Can be used. Carbohydrates may be added as a single substance or a mixture of plural kinds, and sugars originally contained in food materials can also be used.

また、甘味料、酸味料、香料、増粘多糖類等の通常、食品に添加される原料を含有することができる。   Moreover, the raw material normally added to foodstuffs, such as a sweetener, a sour agent, a fragrance | flavor, and a thickening polysaccharide, can be contained.

[実施例]
以下に実施例を挙げて本発明をさらに具体的に説明するが、本発明はそれらの限定されるものではない。実施例中、抗体量の測定は次の方法によった。
[Example]
EXAMPLES The present invention will be described more specifically with reference to examples below, but the present invention is not limited thereto. In the examples, the amount of antibody was measured by the following method.

(抗体量の測定法)
抗牛IgGウサギ免疫血清(ヤガイ製)からプロテインGカラムで吸着画分を分画したものを1次抗体とし、HRP標識抗牛IgG抗体(コスモバイオ製)を2次抗体として、通常の方法でELISAによる定量を行った。抗体標品としては、牛の初乳から得たホエー粉末をプロテインGカラムで常法どおりに3回吸脱着を行った後、透析して低分子画分を除去して得られたプロテインG吸着画分を用い、この標品を用いて標準曲線を求め、試料中の抗体濃度を測定した。
(Measurement method of antibody amount)
An anti-bovine IgG rabbit immune serum (manufactured by potato) fractionated with a protein G column is used as a primary antibody, and an HRP-labeled anti-bovine IgG antibody (manufactured by Cosmo Bio) is used as a secondary antibody in the usual manner. Quantification by ELISA was performed. As an antibody preparation, whey powder obtained from bovine colostrum was adsorbed and desorbed three times on a protein G column in the usual manner, and then dialyzed to remove the low molecular fraction and adsorbed protein G Using this fraction, a standard curve was obtained using this sample, and the antibody concentration in the sample was measured.

[参考例1](乳清タンパク中の抗体含量の測定)
前記測定法に従い、市販の乳清タンパク中の抗体含量を測定したところ、サンラクトN−5(太陽化学(株))、ミラクテール80(森永乳業(株))、ALACEN392(フォンテラジャパン(株))、TATUA902(タツアジャパン(株))はそれぞれ3.9質量%、3.9質量%、3.7質量%、3.8質量%であった。また、ミルクIgG含有濃縮乳清タンパク((株)アオテアロア)の抗体含量は15.5質量%であった。
[Reference Example 1] (Measurement of antibody content in whey protein)
According to the above measurement method, the antibody content in commercially available whey protein was measured. As a result, Sanlacto N-5 (Taiyo Kagaku Co., Ltd.), Miractail 80 (Morinaga Dairy Co., Ltd.), ALACEN 392 (Fontera Japan Co., Ltd.), TATUA902 (Tatsua Japan Co., Ltd.) was 3.9% by mass, 3.9% by mass, 3.7% by mass, and 3.8% by mass, respectively. Moreover, the antibody content of the milk IgG-containing concentrated whey protein (Aotearoa Co., Ltd.) was 15.5% by mass.

[実施例1](抗体含有加工乳)
市販の超高温加熱殺菌された牛乳1リットルにミルク−IgG含有濃縮乳清タンパク((株)アオテアロア)を80gとフラクトオリゴ糖20g添加して十分に撹拌した。このときの糖質含量は6.2質量%であった。これを65℃、30分間の加熱殺菌を行って、抗体含有加工乳を得た。この抗体含有加工乳1g中には10.4mgの乳由来の抗体が含まれており、抗体の残存率は90%であった。
[Example 1] (Antibody-containing processed milk)
80 g of milk-IgG-containing concentrated whey protein (Aotearoa Co., Ltd.) and 20 g of fructooligosaccharide were added to 1 liter of commercially available ultra-high temperature heat-sterilized milk and stirred thoroughly. The carbohydrate content at this time was 6.2% by mass. This was heat sterilized at 65 ° C. for 30 minutes to obtain antibody-containing processed milk. In 1 g of this antibody-containing processed milk, 10.4 mg of milk-derived antibody was contained, and the residual ratio of the antibody was 90%.

[実施例2](抗体含有野菜果汁飲料)
ニンジン汁400g、ホウレンソウ汁100g、トマト果汁300g、リンゴ果汁150g、ミルク−IgG含有濃縮乳清タンパク((株)アオテアロア)30gに他の免疫賦活成分としてアガリクスエキス20gを添加、混合した。このときの糖質含量は4.3質量%であった。これを60℃、30分間加熱殺菌し、抗体含有野菜果汁飲料を得た。この抗体含有野菜果汁飲料1g中には2.4mgの乳由来の抗体が含まれており、抗体の残存率は52%であった。
[Example 2] (Antibody-containing vegetable fruit juice drink)
20 g of Agaricus extract was added and mixed as another immunostimulatory component to 400 g of carrot juice, 100 g of spinach juice, 300 g of tomato juice, 150 g of apple juice, and 30 g of milk-IgG-containing concentrated whey protein (Aotearoa Co., Ltd.). The carbohydrate content at this time was 4.3% by mass. This was heat-sterilized at 60 ° C. for 30 minutes to obtain an antibody-containing vegetable fruit juice drink. In 1 g of this antibody-containing vegetable fruit juice, 2.4 mg of milk-derived antibody was contained, and the residual ratio of the antibody was 52%.

[実施例3](抗体含有豆乳飲料)
市販の豆乳飲料1リットルにサンラクトN−5(太陽化学(株))100gを添加して十分に撹拌したところ糖質含量は4.5質量%であった。これを65℃、30分間加熱殺菌を行い、抗体含有豆乳飲料を得た。この抗体含有豆乳飲料1g中には3.2mgの乳由来の抗体が含まれており、抗体の残存率は89%であった。
[Example 3] (Antibody-containing soymilk beverage)
When 100 g of Sanlacto N-5 (Taiyo Kagaku Co., Ltd.) was added to 1 liter of a commercially available soymilk drink and stirred sufficiently, the sugar content was 4.5% by mass. This was heat sterilized at 65 ° C. for 30 minutes to obtain an antibody-containing soymilk drink. In 1 g of this antibody-containing soymilk beverage, 3.2 mg of milk-derived antibody was contained, and the residual ratio of the antibody was 89%.

[実施例4](抗体含有チョコレート)
細かくしたチョコレート(糖質56質量%含有)を900gを90℃に加熱して溶解し
た。品温が70℃になるまで冷却し、乳清タンパク、ミラクテール80(森永乳業(株))100gを加え、均一とし、抗体含有チョコレートを得た。この抗体含有チョコレート1g中には3.6mgの乳由来の抗体が含まれており、抗体の残存率は93%であった。
[Example 4] (Antibody-containing chocolate)
900 g of finely chopped chocolate (containing 56 mass% of saccharides) was heated to 90 ° C. and dissolved. The product was cooled until the product temperature reached 70 ° C., and 100 g of whey protein and Miractail 80 (Morinaga Milk Industry Co., Ltd.) were added to obtain a uniform antibody-containing chocolate. In 1 g of this antibody-containing chocolate, 3.6 mg of milk-derived antibody was contained, and the residual ratio of the antibody was 93%.

[実施例5](抗体含有アイスクリーム)
卵黄2個とグラニュー糖40gを十分に混合し、そこに生クリーム150ml、市販の超高温加熱殺菌された牛乳50ml、水50ml、乳清タンパク、ALACEN392(フォンテラジャパン(株))15gを添加し良く混ぜ合わせた。このときの糖質含量は13質量%であった。これを60℃、30分間加熱殺菌し、バニラエッセンス少量を均一に添加、冷却後、アイスクリームメーカー(東芝(株))にセットした。出来上がった抗体含有アイスクリーム1g中には1.7mgの乳由来の抗体が含まれており、抗体の残存率は97%であった。
[Example 5] (Antibody-containing ice cream)
Mix 2 egg yolks and 40g of granulated sugar thoroughly, and add 150ml of fresh cream, 50ml of commercial ultra-high temperature heat-sterilized milk, 50ml of water, whey protein, 15g of ALACEN392 (Fontera Japan Co., Ltd.) Mixed. The carbohydrate content at this time was 13% by mass. This was heat-sterilized at 60 ° C. for 30 minutes, a small amount of vanilla essence was uniformly added, cooled, and then set in an ice cream maker (Toshiba Corp.). In 1 g of the resulting antibody-containing ice cream, 1.7 mg of milk-derived antibody was contained, and the residual ratio of the antibody was 97%.

[実施例6](抗体含有ゼリー)
市販の超高温加熱殺菌された牛乳200mlを60℃に加熱し、砂糖50gと少量の水を加えふやかしておいたゼラチン5gを添加し、さらに95℃まで加熱し、完全に溶解させた。これを60℃まで冷却し、乳清タンパク、TATUA902(タツアジャパン(株))を25g添加し、泡立てないようにすばやく撹拌し、ゼリー容器に分注した。このとき糖質含量は20質量%となっていた。その後、60℃の状態を30分間保ち、殺菌した後、5℃にて冷却し、抗体含有ゼリーを得た。この抗体含有ゼリー1g中には3.2mgの乳由来の抗体が含まれており、抗体の残存率は92%であった。
[Example 6] (Antibody-containing jelly)
200 ml of commercially available milk sterilized by ultra-high temperature heating was heated to 60 ° C., 5 g of gelatin added with 50 g of sugar and a small amount of water was added, and further heated to 95 ° C. to completely dissolve. This was cooled to 60 ° C., and 25 g of whey protein, TATAA902 (Tatsua Japan Co., Ltd.) was added, stirred rapidly so as not to foam, and dispensed into a jelly container. At this time, the carbohydrate content was 20% by mass. Then, after maintaining at 60 degreeC for 30 minutes and disinfecting, it cooled at 5 degreeC and obtained the antibody containing jelly. In 1 g of this antibody-containing jelly, 3.2 mg of milk-derived antibody was contained, and the residual ratio of the antibody was 92%.

[実施例7](抗体含有プロセスチーズ)
ナチュラルチーズ(チェダーチーズ)1kgを細かく裁断し、ポリリン酸ナトリウム30gと水100gを添加し、80℃で10分間加熱、溶融させた。品温が65℃になるまで冷却し、乳清タンパク、サンラクトN−5(太陽化学(株))100gを添加し、十分に混捏後に容器に入れ成型した。このときの糖質含量は1.4質量%であった。これを60℃で30分間加熱殺菌し、抗体含有プロセスチーズを得た。この抗体含有プロセスチーズ1g中には3.2mgの乳由来の抗体が含まれており、抗体の残存率は96%であった。
[Example 7] (Antibody-containing process cheese)
1 kg of natural cheese (cheddar cheese) was finely cut, 30 g of sodium polyphosphate and 100 g of water were added, and the mixture was heated and melted at 80 ° C. for 10 minutes. After cooling until the product temperature reached 65 ° C., 100 g of whey protein, Sanlacto N-5 (Taiyo Kagaku Co., Ltd.) was added, and the mixture was sufficiently mixed and molded into a container. The carbohydrate content at this time was 1.4% by mass. This was heat-sterilized at 60 ° C. for 30 minutes to obtain antibody-containing process cheese. In 1 g of this antibody-containing process cheese, 3.2 mg of milk-derived antibody was contained, and the residual ratio of the antibody was 96%.

[実施例8](抗体含有ココア飲料)
ココアパウダー40g、砂糖70g、エリスリトール25g、乳清タンパク、ミラクテール80(森永乳業(株))120gを水1リットルに溶解させた。このときの糖質含量は7.6質量%であった。70℃で30分間加熱殺菌を行い、抗体含有ココア飲料を得た。この抗体含有ココア飲料1g中には1.9mgの乳由来の抗体が含まれており、抗体の残存率は52%であった。
[Example 8] (Antibody-containing cocoa beverage)
40 g of cocoa powder, 70 g of sugar, 25 g of erythritol, whey protein, and 120 g of Miractail 80 (Morinaga Milk Industry Co., Ltd.) were dissolved in 1 liter of water. The carbohydrate content at this time was 7.6% by mass. Sterilization was performed at 70 ° C. for 30 minutes to obtain an antibody-containing cocoa beverage. In 1 g of this antibody-containing cocoa beverage, 1.9 mg of milk-derived antibody was contained, and the residual ratio of the antibody was 52%.

食品に乳清タンパクを添加し、60〜72℃で30分間加熱したときの各食品中の抗体残存率を示すグラフである。It is a graph which shows the antibody residual rate in each foodstuff when adding whey protein to foodstuffs and heating for 30 minutes at 60-72 degreeC. 牛乳に乳清タンパクおよびショ糖を添加し、60〜80℃で30分間加熱したときの抗体残存率を示すグラフである。It is a graph which shows an antibody residual rate when adding whey protein and sucrose to milk and heating at 60-80 degreeC for 30 minutes. 牛乳に乳清タンパクおよびエリスリトールを添加し、60〜80℃で30分間加熱したときの抗体残存率を示すグラフである。It is a graph which shows the antibody residual rate when adding whey protein and erythritol to milk and heating at 60-80 degreeC for 30 minutes.

Claims (6)

乳由来のIgG抗体を含む明らか食品または該明らか食品の乳由来のIgG抗体を含む部分の糖質含量を7.5質量%以上に調製し、The sugar content of the apparent food containing the IgG antibody derived from milk or the portion of the apparent food containing the IgG antibody derived from milk is adjusted to 7.5% by mass or more,
70℃で30分間加熱した後の前記IgG抗体が50%以上残存する条件で加熱殺菌を行うことを特徴とする、It is characterized by performing heat sterilization under the condition that the IgG antibody after heating at 70 ° C. for 30 minutes remains at 50% or more,
IgG抗体含有明らか食品の製造方法。Production method of obvious food containing IgG antibody.
乳由来のIgG抗体の含有量が1.5mg/g以上である請求項1に記載のIgG抗体含有明らか食品の製造方法。The method for producing an IgG antibody-containing apparent food according to claim 1, wherein the content of milk-derived IgG antibody is 1.5 mg / g or more. 乳由来のIgG抗体の含有量が3mg/g以上である請求項1に記載のIgG抗体含有明らか食品の製造方法 Method for producing IgG antibody-containing apparent food according to claim 1, wherein the content of IgG antibody derived from milk is 3 mg / g or more. 乳由来のIgG抗体の含有量が10mg/g以上である請求項1に記載のIgG抗体含有明らか食品の製造方法 Method for producing IgG antibody-containing apparent food according to claim 1, wherein the content of IgG antibody derived from milk is 10 mg / g or more. 乳由来のIgG抗体が乳清タンパク中のIgG抗体である請求項1〜のいずれか1項に記載のIgG抗体含有明らか食品の製造方法The method for producing an IgG antibody-containing apparent food according to any one of claims 1 to 4 , wherein the milk-derived IgG antibody is an IgG antibody in whey protein. IgG抗体含有明らか食品が乳製品または冷菓である請求項1〜のいずれか1項に記載のIgG抗体含有明らか食品の製造方法The method for producing an IgG antibody-containing apparent food according to any one of claims 1 to 5 , wherein the IgG antibody-containing apparent food is a dairy product or a frozen dessert.
JP2004219223A 2004-07-27 2004-07-27 Method for producing apparently IgG-containing food Expired - Fee Related JP4408764B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004219223A JP4408764B2 (en) 2004-07-27 2004-07-27 Method for producing apparently IgG-containing food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004219223A JP4408764B2 (en) 2004-07-27 2004-07-27 Method for producing apparently IgG-containing food

Publications (2)

Publication Number Publication Date
JP2006034173A JP2006034173A (en) 2006-02-09
JP4408764B2 true JP4408764B2 (en) 2010-02-03

Family

ID=35899826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004219223A Expired - Fee Related JP4408764B2 (en) 2004-07-27 2004-07-27 Method for producing apparently IgG-containing food

Country Status (1)

Country Link
JP (1) JP4408764B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023068343A1 (en) * 2021-10-21 2023-04-27 美幸 徳田 Food or beverage, food additive, supplement, cosmetic, antibody, pharmaceutical and production methods thereof

Also Published As

Publication number Publication date
JP2006034173A (en) 2006-02-09

Similar Documents

Publication Publication Date Title
KR101233648B1 (en) Functional composition or food containing whey protein, antibody derived from milk, or antibody
JP5465834B2 (en) Liver function protectant
JP6330255B2 (en) Gel nutrition composition
CN107427058A (en) Muscle synthesis accelerant
Çelik Whey every aspect
JP7763029B2 (en) Fermented composition
JP2006149371A (en) Whey protein food
WO2003063886A1 (en) Helicobacter pylori adhesion inhibitor
JP2019129774A (en) Method for suppressing off-flavor
JP4408764B2 (en) Method for producing apparently IgG-containing food
JP2024170490A (en) Methods for producing high-protein dairy ingredients
JP4382465B2 (en) Mucosal immunostimulant
JP3821981B2 (en) Sterilized milk containing unmodified lactoferrin and method for producing the same
JP6885676B2 (en) Obesity suppressant
WO2019160024A1 (en) Composition for reducing blood pressure and/or for reducing neutral fats
TW202323532A (en) Method for producing peptides
RU2535877C1 (en) Method for production of yoghurt with functional properties
JP4716769B2 (en) Method for producing antihypertensive agent
JP2006325447A (en) Anti-Helicobacter pylori food and drink
JP4005103B2 (en) Bactericidal beverage containing unmodified lactoferrin and method for producing the same
JP2006335725A (en) Composition for improving blood flow
JP2007185134A (en) Packaged beverage and method for producing the same
JPWO2020085517A1 (en) How to make high-protein milk ingredients
WO2006093013A1 (en) Serum cholesterol-reducing agent, process for production of the same, and food composition and pharmaceutical composition having serum cholesterol-reducing effect
JP2022102422A (en) Protein-containing beverage

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070625

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20070626

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20081014

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090313

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090511

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090611

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090709

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090717

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091102

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091110

R150 Certificate of patent or registration of utility model

Ref document number: 4408764

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121120

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121120

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131120

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees